Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-26 @ 7:19 AM
Study NCT ID:
NCT00436566
Status:
COMPLETED
Last Update Posted:
2022-08-05
First Post:
2007-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-22
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-15
First Submit QC Date:
None
Study First Post Date:
2007-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-10-22
Results First Submit QC Date:
None
Results First Post Date:
2012-11-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-12
Last Update Post Date:
2022-08-05
Last Update Post Date Type:
ACTUAL